All lobbying filings

EVERYLIFE FOUNDATION FOR RARE DISEASES

Lobbying for EVERYLIFE FOUNDATION FOR RARE DISEASES

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $40,000.00 expenses · posted Jul 17, 2026

Official filing document

Bills named in this filing 7

S 822
Scientific EXPERT Act of 2025
HR 1532
Scientific EXPERT Act of 2025
HR 4709
Newborn Screening Saves Lives Reauthorization Act of 2025
HR 7118
Genomic Answers for Children’s Health Act of 2026
HR 5509
Safe Step Act
S 2903
Safe Step Act
HR 1414
Cameron’s Law

Lobbying activity 1

Health Issues

S. 822, H.R. 1532 - Scientific EXPERT Act of 2025; H.R. 4709 - Newborn Screening Saves Lives Reauthorization Act of 2025; FY 2027 Appropriations; FDA user fee reauthorization; H.R. 7118 - Genomic Answers for Children's Health Act; H.R. 5509, S. 2903 - Safe Step Act; H.R. 1414 - Cameron's Law

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.